Russ Altman
Internal Medicine · Stanford, CANPI 1497813810
Payments from drug & device makers
$617,074in general payments, 2019–2025
Across 8 payments — averaging $77,134 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$430K
- Janssen Research & Development, LLC$186K
- Pfizer$500
- Genentech, Inc.$148
What the payments were for
- Consulting fees$8,28998%
- Travel & lodging$771%
- Food & beverage$721%
General payments by program year
19
21
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 2 | $430,435 |
| Janssen Research & Development, LLC | 3 | $185,991 |
| Pfizer | 1 | $500 |
| Genentech, Inc. | 2 | $148 |
How this compares
$617,074 in reported general payments places this provider in the 95th percentile of 13,581 internal medicine providers in California.
Other internal medicine in Stanford
- Christian EversullStanford$2.9M
- Andrew ChengSouth San Francisco$55.1M
- Joel NeutelTustin$34.9M
- Donald BrandonSan Diego$34M
- William TownerLos Angeles$27.4M
- Rahul AggarwalSan Francisco$24M
- Masoud AzizadNorthridge$21.1M
- Helen StaceyWalnut Creek$20.4M
- Rohit Loombala Jolla$15.1M
- Zeid KayaliColton$14.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.